Advanced heart failure with reduced ejection fraction at a young age: how long can we wait?
The pharmacotherapy and device therapy for heart failure with reduced ejection fraction (HFrEF) have advanced considerably. However, there are instances where even with optimal therapy following the guidelines’ recommendations, some patients may require heart transplantation (HTX) or left ventricula...
Saved in:
Main Authors: | Arnold Péter Ráduly, Zsófia Pólik, Ágnes Balogh, László Balogh, Kriszti Medvés-Váczi, Ágnes Rácz, Bertalan Kracskó, Zoltán Csanádi, Attila Borbély |
---|---|
Format: | Article |
Language: | English |
Published: |
Promenade Kft
2024-12-01
|
Series: | Cardiologia Hungarica |
Subjects: | |
Online Access: | https://cardiologia.hungarica.eu/archive/2024-issues/2024-6-contents/advanced-heart-failure-with-reduced-ejection-fraction-at-a-young-age-how-long-can-we-wait?article=open |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Quality of Life in Heart Failure Reduced Ejection Fraction (HFrEF) Patients: A Phenomenon of Obesity Paradox
by: Yogi Puji Rachmawan, et al.
Published: (2025-01-01) -
Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
by: Jenni Huusko, et al.
Published: (2020-06-01) -
Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
by: Charlotte Nordberg Backelin, et al.
Published: (2020-06-01) -
Cardiac manifestation of phenylketonuria in adulthood
by: Péter Homródi, et al.
Published: (2024-12-01) -
Successful Management of Refractory Heart Failure and Multi-Organ Dysfunction in a Patient with CRT-D and Acute Pulmonary Edema: A Case Report
by: Marsela Goga, et al.
Published: (2025-01-01)